『Joint Action』のカバーアート

Joint Action

Joint Action

著者： David Hunter PhD FRACP (Rheum)
無料で聴く

このコンテンツについて

Joint Action is a podcast hosted by David Hunter.



As a consequence of isolation, those living with osteoarthritis related disability may become less fit, more depressed and anxious, more socially isolated and gain weight. It is critical at times like this that people with osteoarthritis have their burden and disability minimised and their knowledge of how to manage the disease enhanced. Join David as he interviews the world's leading experts in osteoarthritis.



Professor David Hunter is a rheumatology clinician researcher whose main research focus has been clinical and translational research in osteoarthritis. He is the Florance and Cope Chair of Rheumatology and Professor of Medicine at University of Sydney and the Royal North Shore Hospital, Sydney, Australia. He is ranked as the worlds leading expert in osteoarthritis on Expertscape.com since 2014.

​


You can send in your questions to hello@jointaction.info and follow us on Twitter @jointactionorg and @ProfDavidHunter

Hosted on Acast. See acast.com/privacy for more information.

Joint Action 衛生・健康的な生活 身体的病い・疾患
エピソード
  • Is Methotrexate ready for clinical use? A discussion with Professor Robin Christensen and Dr Anna Dossing

    Is Methotrexate ready for clinical use? A discussion with Professor Robin Christensen and Dr Anna Dossing
    2025/07/20

    Methotrexate is a well-established drug used in oncology, but could it also play a role in managing osteoarthritis? In this episode of Joint Action, Professor David Hunter is joined by Dr Anna Døssing and Professor Robin Christensen to explore the potential of methotrexate as a treatment for osteoarthritis pain.

    They discuss:

    • What methotrexate is and how it works
    • Insights from a recent meta-analysis on its effectiveness and safety
    • Why individual studies show mixed results
    • Whether it might help people with hand or knee OA - especially those with signs of inflammation
    • How dosing and side effects factor into clinical decision-making

    Tune in for an honest, data-driven conversation about repurposing an old drug for a new purpose - and what it could mean for people living with osteoarthritis.


    RESOURCES


    • Editorial: Methotrexate for osteoarthritis—Ready for clinical use and in whom?: https://www.oarsijournal.com/article/S1063-4584(25)00973-2/abstract?


    CONNECT WITH US


    • Twitter: @ProfDavidHunter @jointactionorg
    • Instagram: @osteoarthritisresearchgroup
    • Email: osteoarthritis.research@sydney.edu.au
    • Website: https://www.jointaction.info/podcast


    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    38 分
  • Can a diabetes pill help with knee pain? A discussion with Professor Flavia Cicuttini

    Can a diabetes pill help with knee pain? A discussion with Professor Flavia Cicuttini
    2025/07/06

    Metformin is one of the world’s most prescribed drugs for type 2 diabetes - but could it also help with knee osteoarthritis? In this episode of Joint Action, Prof. David Hunter is joined by Prof. Flavia Cicuttini to unpack the results of a groundbreaking clinical trial that tested metformin as a new treatment for knee pain in people with knee osteoarthritis. Tune in to hear what the study found, how the drug works, who might benefit, and what this could mean for delaying joint replacement.

    RESOURCES

    • Article: Metformin for Knee Osteoarthritis in Patients With Overweight or Obesity: https://jamanetwork.com/journals/jama/article-abstract/2833338

    CONNECT WITH US


    • Twitter: @ProfDavidHunter @jointactionorg
    • Instagram: @osteoarthritisresearchgroup
    • Email: osteoarthritis.research@sydney.edu.au
    • Website: https://www.jointaction.info/podcast

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    23 分
  • Is osteoarthritis treatment worth the cost? With Dr Stephanie Mathieson and Dr Giovanni Ferreira

    Is osteoarthritis treatment worth the cost? With Dr Stephanie Mathieson and Dr Giovanni Ferreira
    2025/06/22

    In this episode of Joint Action, Professor David Hunter is joined by Dr. Stephanie Mathies and Dr. Giovanni Ferreira to unpack the cost-effectiveness of osteoarthritis treatments. They discuss the results of their recent systematic review, which analysed over 100 studies to identify which guideline-recommended treatments provide the best value for money.


    From exercise and medications to injections and surgery, they explore which interventions are truly cost-effective - and which may not be worth the spend. Learn why “simple things” like exercise and education still offer the most value, and what this means for patients, clinicians, and healthcare policy.


    RESOURCES


    Article:

    • The cost-effectiveness of guideline-recommended treatments for osteoarthritis: A systematic review: https://www.oarsijournal.com/article/S1063-4584(25)00972-0/abstract


    CONNECT WITH US


    • Twitter: @ProfDavidHunter @jointactionorg
    • Instagram: @osteoarthritisresearchgroup
    • Email: osteoarthritis.research@sydney.edu.au
    • Website: https://www.jointaction.info/podcast

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    40 分

Joint Actionに寄せられたリスナーの声

カスタマーレビュー：以下のタブを選択することで、他のサイトのレビューをご覧になれます。

Audible.co.jp

Amazon.co.jp
レビューはまだありません。